ERIS.BO
Price:
$1428.7
Market Cap:
$198.33B
Eris Lifesciences Ltd., along with its affiliated companies, operates in India, specializing in the production, promotion, and supply of proprietary pharmaceutical drugs aimed at treating chronic and semi-chronic health conditions. The company's extensive product portfolio encompasses a wide array of branded formulations across numerous therapeutic categories, including treatments for diabetes, infections, cardiovascular ailments, dermatological issues, digestive disorders, blood-related conditions, hormonal imbalances, central nervous system disorders, neuropsychiatric conditions, ear complaints, pain relief, respiratory illnesses, oral health, cosmetic applications, women's health, and ess...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-06-29
Stock Exchange
BSE
Ticker
ERIS.BO
According to Eris Lifesciences Limited’s latest financial reports and current stock price. The company's current PE Ratio is 46.40. This represents a change of 15.48% compared to the average of 40.18 of the last 4 quarters.
The mean historical PE Ratio of Eris Lifesciences Limited over the last ten years is 29.65. The current 46.40 PE Ratio has changed 15.55% with respect to the historical average. Over the past ten years (40 quarters), ERIS.BO's PE Ratio was at its highest in in the December 2024 quarter at 55.84. The PE Ratio was at its lowest in in the March 2026 quarter at 15.74.
Average
29.65
Median
29.06
Minimum
17.07
Maximum
53.77
Discovering the peaks and valleys of Eris Lifesciences Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.31%
Maximum Annual PE Ratio = 53.77
Minimum Annual Increase = -46.78%
Minimum Annual PE Ratio = 17.07
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | 28.62 | -46.78% |
| 2025 | 53.77 | 82.31% |
| 2024 | 29.50 | 44.87% |
| 2023 | 20.36 | -11.64% |
| 2022 | 23.04 | -0.37% |
| 2021 | 23.13 | 35.48% |
| 2020 | 17.07 | -43.25% |
| 2019 | 30.08 | -19.65% |
| 2018 | 37.44 | 11.73% |
| 2017 | 33.51 | -45.91% |
The current PE Ratio of Eris Lifesciences Limited (ERIS.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
37.29
5-year avg
31.06
10-year avg
29.65
Eris Lifesciences Limited’s PE Ratio is less than Neuland Laboratories Limited (68.76), less than Neuland Laboratories Limited (68.76), greater than Jubilant Pharmova Limited (38.32), greater than Jubilant Pharmova Limited (38.32), less than Piramal Enterprises Limited (67.04), greater than Alembic Pharmaceuticals Limited (24.40), greater than Alembic Pharmaceuticals Limited (24.40), less than Wockhardt Limited (138.12), less than Wockhardt Limited (138.12), greater than Pfizer Limited (29.96),
| Company | PE Ratio | Market cap |
|---|---|---|
| 68.76 | $250.26B | |
| 68.76 | $250.26B | |
| 38.32 | $152.72B | |
| 38.32 | $152.72B | |
| 67.04 | $254.86B | |
| 24.40 | $164.60B | |
| 24.40 | $164.70B | |
| 138.12 | $294.22B | |
| 138.12 | $294.26B | |
| 29.96 | $216.58B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eris Lifesciences Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eris Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eris Lifesciences Limited's PE Ratio?
How is the PE Ratio calculated for Eris Lifesciences Limited (ERIS.BO)?
What is the highest PE Ratio for Eris Lifesciences Limited (ERIS.BO)?
What is the 3-year average PE Ratio for Eris Lifesciences Limited (ERIS.BO)?
What is the 5-year average PE Ratio for Eris Lifesciences Limited (ERIS.BO)?
How does the current PE Ratio for Eris Lifesciences Limited (ERIS.BO) compare to its historical average?